Related Experiment Videos
Non-rash skin toxicities associated with novel targeted therapies
Mario E Lacouture1, Scott A Boerner, Patricia M Lorusso
1Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL 48201, USA.
Abstract:
Many novel targeted agents have emerged against a variety of malignancies. Although papulopustular rash is the most commonly observed side effect associated with many of these agents, several non-rash skin toxicities have been identified that frequently result in the delay or discontinuation of anticancer therapy. These toxicities include skin hyperpigmentation, xerosis, pruritus, hair growth and color abnormalities, periungual and nail alterations, and hand-foot skin reaction. It is important to recognize these toxicities, so that they can be diagnosed early and treatment or dose modification can be initiated, if necessary. This review discusses several non-rash dermatologic toxicities observed with targeted therapeutic agents and guidelines for their diagnosis and treatment.
Insights
Novel targeted cancer therapies can cause non-rash skin toxicities like hyperpigmentation and xerosis, impacting treatment. Early recognition and management of these side effects are crucial for continuing anticancer therapy.
Area of Science:
- Oncology
- Dermatology
Background:
- Targeted anticancer agents are increasingly used for various malignancies.
- Papulopustular rash is a common side effect, but other dermatologic toxicities also occur.
Purpose of the Study:
- To review non-rash dermatologic toxicities associated with targeted therapeutic agents.
- To provide guidelines for the diagnosis and treatment of these toxicities.
Main Methods:
- Literature review of non-rash skin toxicities from targeted agents.
- Analysis of reported toxicities including hyperpigmentation, xerosis, pruritus, hair changes, nail changes, and hand-foot skin reaction.
Main Results:
- Several non-rash skin toxicities frequently lead to treatment delay or discontinuation.
- Key toxicities include skin hyperpigmentation, xerosis, pruritus, hair abnormalities, nail alterations, and hand-foot skin reaction.
Conclusions:
- Non-rash dermatologic toxicities are significant side effects of targeted cancer therapies.
- Early diagnosis and appropriate management are essential to prevent treatment interruption.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Drug Toxicity: Dose-Dependent Reactions
Drug Toxicity: Overview
Drug toxicity: Idiosyncratic Reactions